Factory Mutual Insurance Co. acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 3,654 shares of the company's stock, valued at approximately $1,559,000.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Sunbelt Securities Inc. increased its position in shares of HCA Healthcare by 171.7% during the first quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company's stock worth $2,954,000 after purchasing an additional 3,945 shares in the last quarter. Sei Investments Co. lifted its holdings in HCA Healthcare by 27.5% in the 1st quarter. Sei Investments Co. now owns 467,796 shares of the company's stock valued at $221,380,000 after purchasing an additional 100,764 shares in the last quarter. SEB Asset Management AB purchased a new position in HCA Healthcare in the 1st quarter valued at $75,534,000. Darsana Capital Partners LP boosted its stake in HCA Healthcare by 46.7% during the 2nd quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company's stock worth $428,879,000 after purchasing an additional 350,000 shares during the last quarter. Finally, Fund 1 Investments LLC purchased a new stake in shares of HCA Healthcare during the second quarter worth $975,000. Hedge funds and other institutional investors own 62.73% of the company's stock.
More HCA Healthcare News
Here are the key news stories impacting HCA Healthcare this week:
- Positive Sentiment: Hospitals and health insurers rallied after Democrats’ midterm gains, a sector-wide move that likely helped lift HCA. The coverage does not specify which policy changes investors expect. Article: Health insurers, hospitals rally after sweeping midterm win for Democrats
- Positive Sentiment: HCA’s quarterly results beat expectations: adjusted earnings were $7.22 per share versus a $6.65 consensus estimate, and revenue was $19.85 billion versus $19.33 billion. Revenue grew 3.6% year over year. Article: Why HCA Healthcare is a top growth stock for the long term
- Positive Sentiment: Wells Fargo raised its price target on HCA, while Truist reaffirmed its Buy rating and lifted its target to $510 from $495. These moves signal continued analyst support. Article: HCA Healthcare stock gets price target boost from Wells Fargo Article: Truist reaffirms Buy rating
- Positive Sentiment: HCA Houston Healthcare Northwest introduced next-generation robotic-assisted surgical technology, which may strengthen its service offering and competitive position. Article: HCA Houston Healthcare Northwest introduces robotic-assisted surgical technology
- Neutral Sentiment: HCA is planning a $300 million hospital in Cape Coral, with $31 million in city incentives. The project supports expansion, though its investment and execution costs may take time to translate into returns. Article: Cape Coral lands $300 million HCA hospital
- Neutral Sentiment: HCA launched a senior-notes offering; the article listing does not provide details on terms or intended use of proceeds, so the effect on leverage is unclear. Article: HCA Healthcare launches senior notes offering
- Negative Sentiment: Uninsured-patient costs reportedly shifted by $400 million in HCA’s third-quarter payer mix, a potential headwind to profitability. Article: HCA Q3 revenue by payer as uninsured shift costs $400M
- Negative Sentiment: Reports of data breaches involving HCA raise potential privacy, regulatory, and reputational concerns; the article listing does not specify the impact. Article: Data breaches announced by HCA Healthcare
- Negative Sentiment: A law firm announced an investigation into claims on behalf of HCA investors. An investigation is not a finding of wrongdoing, but it can create legal and reputational uncertainty. Article: Pomerantz investigates claims on behalf of HCA investors
Wall Street Analysts Forecast Growth
Several research firms have recently weighed in on HCA. Oppenheimer decreased their price target on shares of HCA Healthcare from $520.00 to $485.00 and set an "outperform" rating on the stock in a research note on Monday, July 27th. Wells Fargo & Company upped their price objective on shares of HCA Healthcare from $381.00 to $468.00 and gave the company an "equal weight" rating in a research note on Monday. TD Cowen increased their price objective on shares of HCA Healthcare from $460.00 to $486.00 and gave the company a "buy" rating in a report on Wednesday, October 28th. Robert W. Baird boosted their target price on HCA Healthcare from $393.00 to $409.00 and gave the stock a "neutral" rating in a report on Wednesday, October 28th. Finally, Truist Financial restated a "buy" rating and issued a $510.00 price target (up from $495.00) on shares of HCA Healthcare in a research report on Tuesday. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $480.13.
Read Our Latest Research Report on HCA
HCA Healthcare Price Performance
Shares of NYSE HCA opened at $510.31 on Thursday. HCA Healthcare, Inc. has a 1 year low of $353.99 and a 1 year high of $556.52. The company has a market capitalization of $106.60 billion, a P/E ratio of 15.44, a P/E/G ratio of 1.55 and a beta of 1.11. The company has a 50 day simple moving average of $440.51 and a 200-day simple moving average of $444.90.
HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Tuesday, October 27th. The company reported $7.22 earnings per share for the quarter, topping the consensus estimate of $6.65 by $0.57. The company had revenue of $19.85 billion during the quarter, compared to analyst estimates of $19.33 billion. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The firm's revenue for the quarter was up 3.6% compared to the same quarter last year. During the same period in the prior year, the business posted $6.96 earnings per share. As a group, research analysts expect that HCA Healthcare, Inc. will post 30.15 EPS for the current year.
HCA Healthcare Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 29th. Shareholders of record on Tuesday, December 15th will be given a dividend of $0.78 per share. The ex-dividend date is Tuesday, December 15th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare's dividend payout ratio (DPR) is currently 10.34%.
HCA Healthcare Company Profile
(
Free Report)
HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women's and children's services, behavioral health and outpatient care.
The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.